In 2023, the mortality rate for stomach malignant neoplasms among women in the UK stood at 4.2 deaths per hundred thousand women. From the forecasted data for 2024-2028, a gradual decline is observed, decreasing from 4.1 in 2024 to 3.7 in 2028. The year-on-year reduction shows a consistent decrease of approximately 2.4% annually from 2026 onwards. Over the five-year period, the compound annual growth rate (CAGR) indicates an average decline of 2.5% per year.
Future trends to watch for include advancements in early detection and treatment options, which could further decrease mortality rates. Tracking lifestyle and dietary changes among the population could also provide insights into shifts in mortality trends.
